ArticleCureus2026
Diffuse Large B-Cell Lymphoma Masquerading as Recurrent Pleural Effusion and Melena: A Case Report and Literature Review.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Diffuse large B-cell lymphoma (DLBCL) is the most common subtype of non-Hodgkin lymphoma, accounting for roughly one-third of adult cases worldwide. Typically, patients have a rapidly enlarging mass at presentation, which could be a lymph node or mass lesion anywhere in the body. However, extranodal manifestations and B symptoms can also be observed, and often two-thirds of the patients already present as advanced-stage DLBCL. Early diagnosis of the disease is essential, as early initiation of treatment for advanced stages gives a five-year survival rate of 50-60%. Therefore, it is imperative to recognize unusual presentations of DLBCL and include it in our differential in patients with uncommon extranodal manifestations. We report the case of a 76-year-old man who presented with recurrent pleural effusion and gastrointestinal bleeding and was ultimately diagnosed with multisite extranodal DLBCL involving the stomach, liver, and pleura. The initial presentation raised concerns for primary thoracic or gastrointestinal malignancy, contributing to diagnostic uncertainty. Early recognition of atypical presentations is essential to avoid delays in diagnosis and facilitate timely treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.